Come up with a name for your new list and we'll add to it:
Arrowhead Pharmaceuticals raised a round of funding on October 04, 2018. Investors include
Johnson & Johnson Innovation – JJDC.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhe…